clinmedКлиническая медицинаClinical Medicine (Russian Journal)0023-21492412-1339ООО «Медицинское информационное агентство»10.30629/0023-2149-2020-98-11-12-772-780clinmed-160Research ArticleОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯORIGINAL INVESTIGATIONSСтратегия формирования приверженности к долгосрочному контролю бронхиальной астмыStrategy of adherence to long-term bronchial asthma control formationhttps://orcid.org/0000-0002-5582-9735СобченкоС. А.SobchenkoS. A.

191015, Санкт-Петербург

191015, Saint Petersburg

https://orcid.org/0000-0001-5829-8696ЕвтюшкинаС. А.EvtyushkinaS. N.

191015, Санкт-Петербург

191015, Saint Petersburg

https://orcid.org/0000-0002-6521-7986ХаритоновМ. А.KharitonovM. A.

194044, Санкт-Петербург

194044, Saint Petersburg

https://orcid.org/0000-0002-1258-3261КазанцевВ. А.KazantsevV. A.

194044, Санкт-Петербург

194044, Saint Petersburg

https://orcid.org/0000-0001-6284-0943БуткоД. Ю.ButkoD. Yu.

194100, Санкт-Петербург

194100, Saint Petersburg

https://orcid.org/0000-0003-1363-6860ЧеркашинД. В.CherkashinD. V.

194044, Санкт-Петербург

194044, Saint Petersburg

https://orcid.org/0000-0002-4830-5220ГришаевС. Л.GrishaevS. L.

Гришаев Сергей Леонидович —  доктор медицинских наук, профессор, заместитель начальника кафедры военно-морской терапии 

194044, Санкт-Петербург

Sergei L. Grishaev — MD, professor, deputy head of Department of Naval Therapy 

194044, Saint Petersburg

grishaev_med@mail.ruФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Минздрава РоссииРоссияNorth-Western State Medical University named after Mechnikоv I.I. of the Ministry of Health of the Russian FederationRussian FederationФГБВОУ ВО «Военно-медицинская академия имени С.М. Кирова» Минобороны РоссииРоссияMilitary Medical Academy named after Kirov S.M. of the Ministry of Defense of the Russian FederationRussian FederationГБОУ ВО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава РоссииРоссияSaint-Petersburg State Pediatric Medical University of the Ministry of Health of the Russian FederationRussian Federation2020170420219811-12772780Copyright © Собченко С.А., Евтюшкина С.А., Харитонов М.А., Казанцев В.А., Бутко Д.Ю., Черкашин Д.В., Гришаев С.Л., 20212021Собченко С.А., Евтюшкина С.А., Харитонов М.А., Казанцев В.А., Бутко Д.Ю., Черкашин Д.В., Гришаев С.Л.Sobchenko S.A., Evtyushkina S.N., Kharitonov M.A., Kazantsev V.A., Butko D.Y., Cherkashin D.V., Grishaev S.L.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinmedjournal.com/jour/article/view/160

 

Рассматривается один из подходов формирования приверженности к долгосрочному лечению больных бронхиальной астмой, основой которого является введение фактора обучения в их терапевтический комплекс. Познавательная стратегия индивидуального, затем группового обучения пациентов в условиях астмашколы способствует пробуждению активности больного на уровне компетентности в отношении ведения своей болезни, партнерства с лечащим врачом. Пациент последовательно приобретает необходимые знания, полезные навыки и уверенность в важности личного участия в лечении своего заболевания, переходя от комплаенса к осознанной приверженности лечению. Показаны существенные преимущества долгосрочного лечения бронхиальной астмы, в котором участвуют обученные пациенты.

One of the approaches to the formation of adherence to long-term treatment of patients with bronchial asthma, the basis of which is the introduction of a learning factor into their therapeutic complex, is considered. The cognitive strategy of individual and group education of patients in the Asthma School environment helps to awaken the patient’s activity at the level of competence in the management of the illness, and cooperation with the attending physician. The patient consistently acquires the necessary knowledge, useful skills and confidence in the importance of personal participation in the treatment of this disease, moving from compliance to informed adherence to treatment. The significant advantages of long-term treatment of bronchial asthma, in which trained patients are involved, are shown.

бронхиальная астмауровни контроляприверженность лечениюобучение пациентовbronchial asthmacontrol levelsadherence to treatmentpatient educationReferencesEngelkes M. et al. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur. Respir. J. 2015;45(2):396– 407. DOI: 10.1183/09031936.00075614Engelkes M. et al. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur. Respir. J. 2015;45(2):396– 407. DOI: 10.1183/09031936.00075614Williams L.K., Pladevall M., Xi H., Peterson E.L. et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J. Allergy Clin. Immunol. 2004;114(6):1288–1293. DOI: 10.1016/j.jaci.2004.09.028Williams L.K., Pladevall M., Xi H., Peterson E.L. et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J. Allergy Clin. Immunol. 2004;114(6):1288–1293. DOI: 10.1016/j.jaci.2004.09.028World Health Organization. Adherence to long-term therapies: Evidence for action. Geneva, Switzerland. 2003. [Electronic resource]. URL: www.who.int/chp/knowledge/publications/adherence_full_report.pdf.World Health Organization. Adherence to long-term therapies: Evidence for action. Geneva, Switzerland. 2003. [Electronic resource]. URL: www.who.int/chp/knowledge/publications/adherence_full_report.pdf.Хьелл Л., Зинглер Д. Теория личности (пер. с англ.). СПб.: Питер, 1997;6:271–303. [Hjelle L., D.Ziegler D. Personality Theories. SPb.: Piter, 3th ed.: McGrow-Hill, 1997;6:271–303. (in Russian)]Глобальная стратегия лечения и профилактики бронхиальной астмы. Пересмотр 2011 г. Под ред. А.С. Белевского. М.: Российское респираторное общество, 2012:108.ГGlobal strategy for asthma management and prevention. Revised 2011. Pod red.A.S. Belevskogo. Moscow: Rossiyskoye respiratornoye obshchestvo, 2012:108. (in Russian)Глобальная стратегия лечения и профилактики бронхиальной астмы. Пересмотр 2014 г. Под ред. А.С. Белевского. М.: Российское респираторное общество, 2015:150.Global strategy for asthma management and prevention. Revised 2015 y. Еd. A.S. Belevskogo. Moscow: Rossiyskoye respiratornoye obshchestvo, 2015:150. (in Russian)Ненашева Н.М. Бронхиальная астма. Современный взгляд на проблему. М.: ГЭОТАР-Медиа, 2018:82–83.Nenasheva N.M. Bronchial asthma. Modern view of the problem. Moscow: GEOTAR-Media, 2018:82–83. (in Russian)]Трофимов В.И., Федосеев Г.Б. Лечение и профилактика бронхиальной астмы. В кн.: Многоликая бронхиальная астма, диагностика, лечение и профилактика. Под ред. Г.Б. Федосеева, В.И. Трофимова, М.А. Петровой. СПб.: Нордмедиздат, 2011;12:320–332.Trofimov V.I., Fedoseyev G.B. Treatment and prevention of bronchial asthma. In book: The many faces of asthma, diagnosis, treatment and prevention. Pod red. G.B. Fedoseyeva, V.I. Trofimova, M.A. Petrovoy. Saint-Petersburg: Nordmedizdat, 2011;12:320–332. (in Russian)Федеральные клинические рекомендации по диагностике и лечению бронхиальной астмы. М.: Российское респираторное общество, 2016:55.Federal’nyye klinicheskiye rekomendatsii po diagnostike i lecheniyu bronkhial’noy astmy. Moscow: Rossiyskoye respiratornoye obshchestvo, 2016:55. (in Russian)Bateman E.D., Boushey H.A, Bousguet J. et all. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Amer. J. Respir. Crit. Care. Med. 2004;170:836–844. DOI: 10.1164/rccm.200401-033OCBateman E.D., Boushey H.A, Bousguet J. et all. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Amer. J. Respir. Crit. Care. Med. 2004;170:836–844. DOI: 10.1164/rccm.200401-033OCPrice D., Fletcher M., van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and Link to Symptoms and Experience (REALISE) survey. NPJ Prim. Care Respir. Med. 2014;24:14009. DOI: 10.1038/npjpcrm.2014.9Price D., Fletcher M., van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and Link to Symptoms and Experience (REALISE) survey. NPJ Prim. Care Respir. Med. 2014;24:14009. DOI: 10.1038/npjpcrm.2014.9Архипов В.В., Григорьева Е.В., Гавришина Е. В. Контроль над бронхиальной астмой в России: результаты многоцентрового наблюдательного исследования НИКА. Пульмонология. 2011; (6):87–93. DOI: 10.18093/0869-0189-2011-0-6-87-93Arkhipov V.V., Grigorieva E.V., Gavrishina E.V. Control of bronchial asthma in Russia: results of a multicenter observational study by NIКА. Pul’monologiya. 2011;(6):87–93. (in Russian) DOI: 10.18093/0869-0189-2011-0-6-87-93Why asthma still kills: the National Review of Asthma Deaths (NRAD) Confidential Enquiry report. Royal College of Physicians. London; 2014.Why asthma still kills: the National Review of Asthma Deaths (NRAD) Confidential Enquiry report. Royal College of Physicians. London; 2014.Haughney J., Price D., Kaplan A. et al. Achieving asthma control in practice: understanding the reasons for poor control. Respir. Med. 2008;102(12):1681–1693. DOI: 10.1016/j.rmed.2008.08.003Haughney J., Price D., Kaplan A. et al. Achieving asthma control in practice: understanding the reasons for poor control. Respir. Med. 2008;102(12):1681–1693. DOI: 10.1016/j.rmed.2008.08.003Clatworthy J. et al. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim. Care Respir. J. 2009;18(4):300–305. DOI: 10.4104/pcrj.2009.00037Clatworthy J. et al. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim. Care Respir. J. 2009;18(4):300–305. DOI: 10.4104/pcrj.2009.00037Melani A.S., Bonavia M., Cilenti V. et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir. Med. 2011;105:930–938. DOI: 10.1016/j.rmed.2011.01.005Melani A.S., Bonavia M., Cilenti V. et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir. Med. 2011;105:930–938. DOI: 10.1016/j.rmed.2011.01.005Virchow J.C., Crompton G.K., Dal Negro R. Importance of inhaler devices in the management of airway disease. Respir. Med. 2008;102(1):10–19. DOI: 10.1016/j.rmed.2007.07.031Virchow J.C., Crompton G.K., Dal Negro R. Importance of inhaler devices in the management of airway disease. Respir. Med. 2008;102(1):10–19. DOI: 10.1016/j.rmed.2007.07.031Clatworthy J. et al. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim. Care Respir. J. 2009;18(4):300–305. DOI: 10.4104/pcrj.2009.00037Clatworthy J. et al. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim. Care Respir. J. 2009;18(4):300–305. DOI: 10.4104/pcrj.2009.00037Di Matteo M.R. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med. Care. 2004;42(3):200–209. DOI: 10.1097/01.mlr.0000114908.90348.f9Di Matteo M.R. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med. Care. 2004;42(3):200–209. DOI: 10.1097/01.mlr.0000114908.90348.f9Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest. 2006;130:65–72. [Electronic resource]. URL: https://www.eu-patient.eu/globalassets/policy/adherence-compliance-concordance/adherence-paper-final-rev_external.pdf.Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest. 2006;130:65–72. [Electronic resource]. URL: https://www.eu-patient.eu/globalassets/policy/adherence-compliance-concordance/adherence-paper-final-rev_external.pdf.van Boven J.F., Trappenburg J.C., van der Molen T., Chavannes N.H. Towards tailored and targeted adherence assessment to optimise asthma management. NPJ Prim. Care Resp. Med. 2015;25:15046. DOI: 10.1038/npjpcrm.2015.46van Boven J.F., Trappenburg J.C., van der Molen T., Chavannes N.H. Towards tailored and targeted adherence assessment to optimise asthma management. NPJ Prim. Care Resp. Med. 2015;25:15046. DOI: 10.1038/npjpcrm.2015.46Ненашева Н.М. Как повысить приверженность лечения и улучшить контроль при бронхиальной астме, или невозможное возможно. Эффективная фармакотерапия. 2019;15(15):18–23. DOI: 10.33978/2307-3586-2019-15-15-18-23Nenasheva N.M. how to increase adherence to treatment and improve control for bronchial asthma, or the impossible is possible. Effektivnaya farmakoterapiya. 2019;15(15):18–23. (in Russian). DOI:10.33978/2307-3586-2019-15-15-18-23Шварц Ю.Г., Наумова Е.А. Приверженность пациентов к лечению с позиций доказательной медицины. Международный медицинский журнал. 2005;3:120–125.Schwartz Yu.G., Naumova E.A. Patients‘ Commitment to treatment from the standpoint of evidence-based medicine. Mezhdunarodnyy meditsinskiy zhurnal. 2005;3:120–125. (in Russian)Jin J., Sklar G.E., Min Sen Oh V., Chuen Li S. Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther. Clin. Risk Manag. 2008;4(1):269–286. DOI: 10.2147/tcrm.s1458Jin J., Sklar G.E., Min Sen Oh V., Chuen Li S. Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther. Clin. Risk Manag. 2008;4(1):269–286. DOI: 10.2147/tcrm.s1458Pedersen, S. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma Control Study. S. Pedersen [et al.]. J. Allergy Clin. Immunol. 2007;120(5):1036–1042. DOI: 10.1016/j.jaci.2007.07.016Pedersen, S. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma Control Study. S. Pedersen [et al.]. J. Allergy Clin. Immunol. 2007;120(5):1036–1042. DOI: 10.1016/j.jaci.2007.07.016Собченко С.А. Особенности течения и организация длительного лечения поздней астмы. Диссертация… док. мед. наук. СПб, 1997:302.Sobchenko S.A. Features of the course and organization of long-term treatment of late asthma. Dissertatsiya… dok. med. nauk. SPb, 1997:302. (in Russian)Ignasio-Garcio J.M. Gonsales-Santos P. Asthma self-management education program by me monitoring of peak expiratory flow. Amer. J. Respir. Crit. Care Med. 1995;151:353–359. DOI: 10.1164/ajrccm.151.2.7842191Ignasio-Garcio J.M. Gonsales-Santos P. Asthma self-management education program by me monitoring of peak expiratory flow. Amer. J. Respir. Crit. Care Med. 1995;151:353–359. DOI: 10.1164/ajrccm.151.2.7842191Partridge M.R. Patient education and delivery of care. Asthma. European respiratory monograph. 2003;8:449–453.Partridge M.R. Patient education and delivery of care. Asthma. European respiratory monograph. 2003;8:449–453.Reddel H.K. Peak flow monitoring in clinical practice and clinical asthma trials. Curr. Opin. Pulm. Med. 2006;12(1):75–81. DOI: 10.1097/01.mcp.0000198065.65704.08Reddel H.K. Peak flow monitoring in clinical practice and clinical asthma trials. Curr. Opin. Pulm. Med. 2006;12(1):75–81. DOI: 10.1097/01.mcp.0000198065.65704.08Цой А.Н., Архипов В.В. Бронхиальная астма: новые решения. М.: ООО «Медицинское информационное агентство», 2007:38–46.Tsoy A.N., Arkhipov V.V. Bronchial asthma: new solutions. Moscow: OOO «Meditsinskoye informatsionnoye agentstvo», 2007:38–46. (in Russian)International consensus report on diagnosis and management of asthma. Bethesda, Maryland, USA: National Heart, Lung and Blood Institutes of Health. Bethesda, 1992. Eur. Respir. J. Publication no. 92-3091. 1992;(5):601–641.International consensus report on diagnosis and management of asthma. Bethesda, Maryland, USA: National Heart, Lung and Blood Institutes of Health. Bethesda, 1992. Eur. Respir. J. Publication no. 92-3091. 1992;(5):601–641.Поспелова С.Н. Клинико-лабораторные данные и показатели качества жизни в контроле течения бронхиальной астмы (по данным долгосрочного лечения пациентов «Астма-школы»). Диссертация ... канд. мед. наук. СПб., 2012:203.Pospelova S.N. Clinical and laboratory data and indicators of quality of life in the control of the course of bronchial asthma (according to long-term treatment of patients «Аsthma-school»). Dissertatsiya ... kand. med. nauk. SPb., 2012:203. (in Russian)Chrystyn H., Price D. Not all asthma inhalers are the same: factors to consider when prescribing an inhaler. Prim. Care Respir. J. 2009;18(4):243–249. DOI: 10.4104/pcrj.2009.00029Chrystyn H., Price D. Not all asthma inhalers are the same: factors to consider when prescribing an inhaler. Prim. Care Respir. J. 2009;18(4):243–249. DOI: 10.4104/pcrj.2009.00029Haynes R.B., McDonald H., Garg A.X., Montague P.R. Interventions for helping patients to follow prescriptions for medication (Cochrane review). Cochrane Database Syst. Rev. 2002;(2):CD000011. DOI: 10.1002/14651858.CD000011Haynes R.B., McDonald H., Garg A.X., Montague P.R. Interventions for helping patients to follow prescriptions for medication (Cochrane review). Cochrane Database Syst. Rev. 2002;(2):CD000011. DOI: 10.1002/14651858.CD000011McKinstry B. Do patients wish to be involved in decisionmaking in the consultation? A cross sectional survey with video vignettes. BMJ. 2000;321:867–871 DOI: 10.1136/bmj.321.7265.867McKinstry B. Do patients wish to be involved in decisionmaking in the consultation? A cross sectional survey with video vignettes. BMJ. 2000;321:867–871 DOI: 10.1136/bmj.321.7265.867Worsley S, Snowise N., Halpin D.M.G. Clinical effectiveness of oncedaily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design. ERJ Open Research. 2019;(5):00061-2019; DOI: 10.1183/23120541.00061-2019Worsley S, Snowise N., Halpin D.M.G. Clinical effectiveness of oncedaily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design. ERJ Open Research. 2019;(5):00061-2019; DOI: 10.1183/23120541.00061-2019

The authors declare that there are no conflicts of interest present.